Treasurer of the State of North Carolina’s Iovance Biotherapeutics IOVA Stock Holding History

Treasurer of the State of North Carolina’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54,917	Closed	-$914K	–	1046
2022 Q1	$914K	Buy	54,917 +878	+2%	+$13.6K	0.01%	965
2021 Q4	$1.03M	Buy	54,039 +990	+2%	+$21.8K	0.01%	963
2021 Q3	$1.31M	Buy	53,049 +2,509	+5%	+$59.1K	0.01%	942
2021 Q2	$1.31M	Buy	50,540 +10	+0%	+$260	0.01%	947
2021 Q1	$1.6M	Sell	50,530 -130	-0.3%	-$5.39K	0.01%	865
2020 Q4	$2.35M	Buy	50,660 +120	+0.2%	+$4.76K	0.02%	703
2020 Q3	$1.66M	Buy	50,540 +880	+2%	+$27K	0.01%	750
2020 Q2	$1.36M	Buy	+49,660	New	+$1.63M	0.01%	809

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Treasurer of the State of North Carolina's IOVA Position: Q2 2022 in Review

Treasurer of the State of North Carolina sold out of Iovance Biotherapeutics (IOVA) in Q2 2022, closing a stake of 54,917 shares — an estimated $914K sold.

Treasurer of the State of North Carolina first reported a position in IOVA in Q2 2020 and held it in 8 quarters. The position peaked at $2.35M in Q4 2020. 237 funds tracked by Wall St. Rank hold IOVA as of Q2 2022.

Treasurer of the State of North Carolina reported no remaining Iovance Biotherapeutics position as of Q2 2022 after selling out during the quarter.
Treasurer of the State of North Carolina sold 54,917 Iovance Biotherapeutics shares in Q2 2022, an estimated $914K.
Treasurer of the State of North Carolina first reported a position in Iovance Biotherapeutics in Q2 2020 and held it in 8 quarters.
Treasurer of the State of North Carolina's Iovance Biotherapeutics position peaked at $2.35M in Q4 2020.
237 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2022.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2022, filed 2 Aug 2022.